Cargando…
Infection: a Cause of and Cure for Cancer
PURPOSE OF REVIEW: This article provides a brief overview of the role that infections play in cancer emergence and cancer treatment. RECENT FINDINGS: A select number of pathogens have been reported to increase the incidence of specific cancers (directly through altering gene expression or indirectly...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686242/ https://www.ncbi.nlm.nih.gov/pubmed/29201631 http://dx.doi.org/10.1007/s40495-017-0109-y |
_version_ | 1783278752618250240 |
---|---|
author | Newman, Jenna H. Zloza, Andrew |
author_facet | Newman, Jenna H. Zloza, Andrew |
author_sort | Newman, Jenna H. |
collection | PubMed |
description | PURPOSE OF REVIEW: This article provides a brief overview of the role that infections play in cancer emergence and cancer treatment. RECENT FINDINGS: A select number of pathogens have been reported to increase the incidence of specific cancers (directly through altering gene expression or indirectly through inducing chronic inflammation). These have been referred to as oncogenic pathogens. Conversely, a subset of pathogens has been demonstrated to preferentially cause lysis of tumor cells, leading to tumor regression and improved anti-tumor immunity. These have been termed oncolytic pathogens. However, the contribution of non-oncogenic, non-oncolytic pathogens to both tumor growth and regression is likewise being increasingly recognized. SUMMARY: Pathogens have both the ability to cause and cure cancer. However, the mechanisms underlying these pathogen-mediated outcomes are not fully understood. With the recent emergence of interest in the immunotherapy of cancer, it is important that future studies focus specifically on preventing the negative effects of oncogenic infections, deconstructing the positive role of oncolytic pathogens, and finally providing insight into the dual roles of non-oncolytic, non-oncogenic pathogens so that anti-pathogen immune responses can be harnessed as a transformative means to treat cancer. |
format | Online Article Text |
id | pubmed-5686242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-56862422017-11-28 Infection: a Cause of and Cure for Cancer Newman, Jenna H. Zloza, Andrew Curr Pharmacol Rep Immunology and Inflammation (W Gause and L Covey, Section Editors) PURPOSE OF REVIEW: This article provides a brief overview of the role that infections play in cancer emergence and cancer treatment. RECENT FINDINGS: A select number of pathogens have been reported to increase the incidence of specific cancers (directly through altering gene expression or indirectly through inducing chronic inflammation). These have been referred to as oncogenic pathogens. Conversely, a subset of pathogens has been demonstrated to preferentially cause lysis of tumor cells, leading to tumor regression and improved anti-tumor immunity. These have been termed oncolytic pathogens. However, the contribution of non-oncogenic, non-oncolytic pathogens to both tumor growth and regression is likewise being increasingly recognized. SUMMARY: Pathogens have both the ability to cause and cure cancer. However, the mechanisms underlying these pathogen-mediated outcomes are not fully understood. With the recent emergence of interest in the immunotherapy of cancer, it is important that future studies focus specifically on preventing the negative effects of oncogenic infections, deconstructing the positive role of oncolytic pathogens, and finally providing insight into the dual roles of non-oncolytic, non-oncogenic pathogens so that anti-pathogen immune responses can be harnessed as a transformative means to treat cancer. Springer International Publishing 2017-10-05 2017 /pmc/articles/PMC5686242/ /pubmed/29201631 http://dx.doi.org/10.1007/s40495-017-0109-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Immunology and Inflammation (W Gause and L Covey, Section Editors) Newman, Jenna H. Zloza, Andrew Infection: a Cause of and Cure for Cancer |
title | Infection: a Cause of and Cure for Cancer |
title_full | Infection: a Cause of and Cure for Cancer |
title_fullStr | Infection: a Cause of and Cure for Cancer |
title_full_unstemmed | Infection: a Cause of and Cure for Cancer |
title_short | Infection: a Cause of and Cure for Cancer |
title_sort | infection: a cause of and cure for cancer |
topic | Immunology and Inflammation (W Gause and L Covey, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686242/ https://www.ncbi.nlm.nih.gov/pubmed/29201631 http://dx.doi.org/10.1007/s40495-017-0109-y |
work_keys_str_mv | AT newmanjennah infectionacauseofandcureforcancer AT zlozaandrew infectionacauseofandcureforcancer |